Document Detail


Rapid intravenous infusion of 20 ml/kg saline does not impair resting pulmonary gas exchange in the healthy human lung.
MedLine Citation:
PMID:  19910335     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rapid infusion of intravenous saline, a model of pulmonary interstitial edema, alters the distribution of pulmonary perfusion, raises pulmonary capillary blood volume, and increases bronchial wall thickness in humans. We hypothesized that infusion would disrupt pulmonary gas exchange by increasing ventilation/perfusion ((.)VA/(.)Q) inequality as opposed to a diffusive impairment in O2 exchange. Seven males (26 +/- 3 yr; FEV1: 110 +/- 16% predicted.) performed spirometry and had (.)VA/(.)Q mismatch measured using the multiple inert gas elimination technique, before and after 20 ml/kg iv of normal saline delivered in approximately 30 min. Infusion increased thoracic fluid content from transthoracic impedance by 12% (P < 0.0001) and left FVC unchanged but reduced expiratory flows (FEF(25-75) falling from 5.1 +/- 0.4 to 4.2 +/- 0.4 l/s, P < 0.05). However, (.)VA/(.)Q mismatch as measured by the log standard deviation of the ventilation (LogSD(.)V) and perfusion (LogSD(.)Q) distributions remained unchanged; LogSD(.)V: 0.40 +/- 0.03 pre, 0.38 +/- 0.04 post, NS; LogSD(.)Q: 0.38 +/- 0.03 pre, 0.37 +/- 0.03 post, NS. There was no significant change in arterial PO2 (99 +/- 2 pre, 99 +/- 3 mmHg post, NS) but arterial PCO2 was decreased (38.7 +/- 0.6 pre, 36.8 +/- 1.2 mmHg post, P < 0.05). Thus, infusion compressed small airways and caused a mild degree of hyperventilation. There was no evidence for a diffusive limitation to O2 exchange, with the measured-predicted alveolar-arterial oxygen partial pressure difference being unaltered by infusion at FIO2 = 0.125 (4.3 +/- 1.0 pre, 5.2 +/- 1.0 post, NS). After infusion, the fraction of perfusion going to areas with (.)VA/(.)Q < 1 was increased when a subject breathed a hyperoxic gas mixture [0.72 +/- 0.06 (FIO2 = 0.21), 0.80 +/- 0.06 (FIO2 = 0.30), P < 0.05] with similar effects on ventilation in the face of unchanged (.)VA and (.)Q. These results suggest active control of blood flow to regions of decreased ventilation during air breathing, thus minimizing the gas exchange consequences.
Authors:
G Kim Prisk; I Mark Olfert; Tatsuya J Arai; Peter D Wagner; Susan R Hopkins
Related Documents :
987725 - Change in pulmonary venous admixture with varying inspired oxygen.
21601495 - A screening test for capsaicin-stimulated salivary flow using filter paper: a study for...
1115245 - Reflection coefficients of dog lung endothelium to small hydrophilic solutes.
8452825 - The effect of interstitial hyperthermia on local pulmonary blood flow and lung parenchyma.
17111725 - Blood transfusion therapy in neonates admitted into the special care baby unit (scbu) o...
6289675 - Lack of solvent drag of nacl and nahco3 in rabbit proximal tubules.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-11-12
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  108     ISSN:  1522-1601     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-07     Completed Date:  2010-03-17     Revised Date:  2012-05-16    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  53-9     Citation Subset:  IM    
Affiliation:
Dept. of Medicine, Univ. of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0931, USA. kprisk@ucsd.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acid-Base Equilibrium / drug effects,  physiology*
Adult
Humans
Infusions, Intravenous
Lung / drug effects,  physiology*
Male
Oxygen Consumption / drug effects,  physiology*
Pulmonary Gas Exchange / drug effects,  physiology*
Saline Solution, Hypertonic / administration & dosage*
Grant Support
ID/Acronym/Agency:
HL-080203/HL/NHLBI NIH HHS; HL-081171/HL/NHLBI NIH HHS; HL-084281/HL/NHLBI NIH HHS; R01 HL081171/HL/NHLBI NIH HHS; R01 HL081171-04/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Saline Solution, Hypertonic
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy.
Next Document:  Influence of Acetaminophen on Performance during Time Trial Cycling.